- Home
- USAS vs PEPG Comparison
USAS vs PEPG Comparison
Compare USAS & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- PEPG
- Stock Information
- Founded
- USAS 1998
- PEPG 2018
- Country
- USAS Canada
- PEPG United States
- Employees
- USAS N/A
- PEPG N/A
- Industry
- USAS Metal Mining
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- PEPG Health Care
- Exchange
- USAS Nasdaq
- PEPG Nasdaq
- Market Cap
- USAS 122.4M
- PEPG 118.3M
- IPO Year
- USAS N/A
- PEPG 2022
- Fundamental
- Price
- USAS $0.40
- PEPG $3.63
- Analyst Decision
- USAS Strong Buy
- PEPG Buy
- Analyst Count
- USAS 1
- PEPG 3
- Target Price
- USAS $0.80
- PEPG $14.67
- AVG Volume (30 Days)
- USAS 714.8K
- PEPG 297.7K
- Earning Date
- USAS 11-07-2024
- PEPG 11-07-2024
- Dividend Yield
- USAS N/A
- PEPG N/A
- EPS Growth
- USAS N/A
- PEPG N/A
- EPS
- USAS N/A
- PEPG N/A
- Revenue
- USAS $97,123,000.00
- PEPG N/A
- Revenue This Year
- USAS $21.84
- PEPG N/A
- Revenue Next Year
- USAS $46.00
- PEPG N/A
- P/E Ratio
- USAS N/A
- PEPG N/A
- Revenue Growth
- USAS 14.33
- PEPG N/A
- 52 Week Low
- USAS $0.20
- PEPG $2.90
- 52 Week High
- USAS $0.54
- PEPG $19.30
- Technical
- Relative Strength Index (RSI)
- USAS 52.20
- PEPG 27.87
- Support Level
- USAS $0.35
- PEPG $4.00
- Resistance Level
- USAS $0.44
- PEPG $5.72
- Average True Range (ATR)
- USAS 0.03
- PEPG 0.68
- MACD
- USAS -0.00
- PEPG -0.09
- Stochastic Oscillator
- USAS 60.00
- PEPG 18.48
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.